Douglas C. Rice's most recent trade in Mimedx Group Inc was a trade of 12,749 Common Stock done at an average price of $6.3 . Disclosure was reported to the exchange on July 3, 2025.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Mimedx Group Inc | Douglas C. Rice | Chief Financial Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 6.34 per share. | 03 Jul 2025 | 12,749 | 188,024 (0%) | 0% | 6.3 | 80,829 | Common Stock |
| Mimedx Group Inc | Douglas C. Rice | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Mar 2025 | 45,929 | 200,773 (0%) | 0% | 0 | Common Stock | |
| Mimedx Group Inc | Douglas C. Rice | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Mar 2025 | 36,486 | 201,241 | - | - | Stock Options | |
| Mimedx Group Inc | Douglas C. Rice | Chief Financial Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 6.79 per share. | 08 Jul 2024 | 12,749 | 147,929 (0%) | 0% | 6.8 | 86,566 | Common Stock |
| Mimedx Group Inc | Douglas C. Rice | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Mar 2024 | 70,755 | 164,755 | - | - | Stock Options | |
| Mimedx Group Inc | Douglas C. Rice | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Mar 2024 | 58,478 | 160,678 (0%) | 0% | 0 | Common Stock | |
| Mimedx Group Inc | Douglas C. Rice | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 05 Jul 2023 | 97,200 | 97,200 (0%) | 0% | 0 | Common Stock | |
| Mimedx Group Inc | Douglas C. Rice | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 05 Jul 2023 | 94,000 | 94,000 | - | - | Stock Options | |
| Orthofix Medical Inc | Douglas C. Rice | CFO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 11 Apr 2022 | 14,937 | 107,679 (0%) | 0% | 0 | Common Stock | |
| Orthofix Medical Inc | Douglas C. Rice | CFO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 33.04 per share. | 01 Apr 2022 | 1,317 | 93,490 (0%) | 0% | 33.0 | 43,514 | Common Stock |
| Orthofix Medical Inc | Douglas C. Rice | CFO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 33.04 per share. | 01 Apr 2022 | 867 | 94,807 (0%) | 0% | 33.0 | 28,646 | Common Stock |
| Orthofix Medical Inc | Douglas C. Rice | CFO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 33.04 per share. | 01 Apr 2022 | 385 | 93,105 (0%) | 0% | 33.0 | 12,720 | Common Stock |
| Orthofix Medical Inc | Douglas C. Rice | CFO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 33.04 per share. | 01 Apr 2022 | 363 | 92,742 (0%) | 0% | 33.0 | 11,994 | Common Stock |
| Orthofix Medical Inc | Douglas C. Rice | CFO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Feb 2022 | 22,131 | 22,131 | - | - | Performance Share Units | |
| Orthofix Medical Inc | Douglas C. Rice | CFO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Feb 2022 | 22,131 | 95,674 (0%) | 0% | 0 | Common Stock | |
| Orthofix Medical Inc | Douglas C. Rice | CFO | Purchase of securities on an exchange or from another person at price $ 30.05 per share. | 19 Nov 2021 | 1,400 | 73,543 (0%) | 0% | 30.1 | 42,070 | Common Stock |
| Orthofix Medical Inc | Douglas C. Rice | CFO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 40.48 per share. | 03 Jul 2021 | 373 | 70,370 (0%) | 0% | 40.5 | 15,099 | Common Stock |
| Orthofix Medical Inc | Douglas C. Rice | CFO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Apr 2021 | 13,394 | 13,394 | - | - | Performance Share Units | |
| Orthofix Medical Inc | Douglas C. Rice | CFO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Apr 2021 | 13,394 | 71,122 (0%) | 0% | 0 | Common Stock | |
| Orthofix Medical Inc | Douglas C. Rice | CFO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 42.93 per share. | 01 Apr 2021 | 3,029 | 67,708 (0%) | 0% | 42.9 | 130,035 | Common Stock |
| Orthofix Medical Inc | Douglas C. Rice | CFO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 42.93 per share. | 01 Apr 2021 | 867 | 66,841 (0%) | 0% | 42.9 | 37,220 | Common Stock |
| Orthofix Medical Inc | Douglas C. Rice | CFO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 42.93 per share. | 01 Apr 2021 | 385 | 70,737 (0%) | 0% | 42.9 | 16,528 | Common Stock |
| Orthofix Medical Inc | Douglas C. Rice | CFO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 42.93 per share. | 01 Apr 2021 | 363 | 66,478 (0%) | 0% | 42.9 | 15,584 | Common Stock |